Source link : https://www.newshealth.biz/health-news/delgocitinib-approved-in-europe-for-chronic-hand-eczema/
The European Commission has approved the topical pan-JAK inhibitor delgocitinib for adults with moderate to severe hand eczema, for whom topical corticosteroids are inadequate or inappropriate, the manufacturer announced on September 23. The development is based on results from the phase 3 program of delgocitinib cream (Anzupgo), which includes the DELTA 1 and DELTA 2 […]
Author : News Health
Publish date : 2024-10-01 06:58:41
Copyright for syndicated content belongs to the linked Source.
Categories